Abstract: Advancements in nanotechnology and molecular biology have promoted the development of a diverse range of models to intervene in various disorders (from diagnosis to treatment and even theranostics). Manganese dioxide nanosheets (MnO 2 NSs), a typical two-dimensional (2D) transition metal oxide of nanomaterial that possesses unique structure and distinct properties have been employed in multiple disciplines in recent decades, especially in the field of biomedicine, including biocatalysis, fluorescence sensing, magnetic resonance imaging and cargo-loading functionality. A brief overview of the different synthetic methodologies for MnO 2 NSs and their state-of-the-art biomedical applications is presented below, as well as the challenges and future perspectives of MnO 2 NSs.
Introduction
Advances in nanotechnology and molecular biochemistry, the ability to decrypt and elaborate multiple artificial materials, the continuous search for new targets, and the disentangling of diverse signaling pathways of many medical disorders have had a conspicuous influence on modern medical practices. [1] [2] [3] [4] Among the various nanomaterials designed for biomedical applications, two-dimensional (2D) materials, especially transition metal dichalcogenides (eg, MoS 2 , WS 2 , TiS 2 , MoSe 2 , and WSe 2 ) 5 and transition metal oxides (TMOs, eg, MnO 2 ), 6 have received a substantial amount of recent attention due to their distinct structure-property relationships in multiple fields, eg, optoelectronics, spintronics, catalysis, defect engineering, and energy-related applications. [7] [8] [9] Among these materials, manganese oxides have attracted increasing attention because Mn is the twelfth most common element on the planet and the third most abundant transition element after iron and titanium. 10 Manganese (II) ions function as cofactors in a number of enzymes with varying functionalities as well as being key components in the oxygen-evolving complexes of photosynthetic plants.
similar common features, eg, ultralarge specific surface areas and high surface-to-volume ratios, allowing easy contact between reactant molecules and the active sites, thus providing enhanced catalytic activities 16 as well as unique optical properties (described below) and excellent photothermal therapy (PTT), etc. 17 MnO 2 nanosheets (MnO 2 NSs) are composed of MnO 6 octahedra that share edges, with manganese ions occupying the centers of the octahedra and being coordinated to the six nearest oxygen ions, while each oxygen ion is coordinated to the three nearest manganese ions. 18, 19 Similar to the structures of other 2D materials, MnO 2 NSs possess high specific surface areas and a thickness of nanometers to micrometers. Moreover, the redox reactions between MnO 2 and glutathione (GSH) in acidic environment have favored their applications in activatable fluorescent biosensors, controlled drug delivery and activable T 1 -MR imaging. [20] [21] [22] As a class of novel and facilely synthesized 2D TMOs with good biocompatibility, MnO 2 NSs have received increased attention across a vast range of disciplines, especially biomedicine. In this review, we aim to provide an overview of the state-of-the-art syntheses, biomedical applications, toxicological assessments and challenges/opportunities in the research field of MnO 2 NSs. First, various synthetic strategies for the preparation of MnO 2 NSs are introduced. Then, we briefly discuss their main biomedical applications. Furthermore, the in vitro and in vivo toxicological evaluations are highlighted. Ultimately, we provide some personal perspectives on the future directions of this promising research field.
Synthesis of manganese dioxide nanosheets (MnO 2 NSs)
As a class of 2D nanomaterials, NSs are characterized by their nanometer thicknesses as well as lateral dimensions ranging from the submicrometers to micrometer scales. MnO 2 NSs with extremely large surface-area-to-mass ratios (SMRs) display a number of distinctive physicochemical properties compared with their bulk form. Hence, the synthesis of MnO 2 NSs is of great significance for a variety of novel biomedical applications. To date, several methods have been developed for the preparation of MnO 2 NSs. In general, these methods can be classified into two categories: top-down and bottom-up approaches, as is also true of other types of 2D nanomaterials. 23 In ) to hinder the rapid precipitation of Mn(OH) 2 . However, their precipitate consisted of multiple layers with thicknesses of 10 nanometers or greater (ie, over 10 layers). Moreover, the time-consuming process (at least 3 days) was unavoidable. To address these issues, inspired by the single-step route reported by Yoon for the synthesis of titanate dioxide nanosheets (Ti 1-δ O 2 NSs), Kazuya Kai and coworkers attempted to prepare MnO 2 NSs with hydrogen peroxide (H 2 O 2 ) as an oxidant in an alkaline medium and TMA cations for the exfoliation of layered H/MnO 2 . However, unlike the method form Yoon, their reaction readily proceeded at ambient temperature instead of heating under reflux (Figure 1 ). 2 and ethanol), the use of the MES buffer as the reducing agent showed the best results (Figure 2A ). 28 Later, in 2015, Yin and coworkers developed a facile template-free, one-step and one-phase reductive strategy to synthesize single-layered MnO 2 NSs with sodium dodecylsulfate (SDS) as the reducing agent. In their system, SDS not only played the role of a precursor of dodecanol to reduce KMnO 4 but also was a structure-directing agent to promote the formation of the MnO 2 monosheets, which opened up the possibility of constructing other NS without the use of an exfoliation reagent ( Figure 2B ). 29 Indeed, this reductive method was more facile in both principle and practice because a variety of reductants could be selected. Furthermore, the synthetic process for the MnO 2 NSs was more controllable. Nonetheless, an inevi- Figure 3 ). 67 The oxidation of the pale yellowcolored substrate (TMB) to the blue-oxidized product (ox-TMB) indicated the catalytic activity of the MnO 2 NSs. Based on this, Liu and colleagues have developed a selective, rapid, and reliable colorimetric assay for the determination of GSH because GSH can further lead to a concentration-dependent reduction of ox-TMB and a proportional decrease in the absorption at ca. 650 nm ( Figure 4A ). 68 Notwithstanding their utilization as a group of nanozymes with oxidase activity, MnO 2 NSs can also act as indirect DNA partzymes to some extent. Recently, Zhao et al fabricated a MnO 2 NS-powered target/probe Janus protected DNA nanomachine to achieve RNA imaging. In this DNA machine, the MnO 2 NSs were utilized as both promoters for the cellular uptake of DNA and generators of Mn 2+ as indispensable DNAzyme cofactors, ensuring the efficiency of catalytic cleavage ( Figure 4B ). by GSH, Wang and coworkers employed fluorescent CDs and MnO 2 NSs as an energy donor-acceptor pair to construct a nanoplatform for GSH detection ( Figure 5A ). 86 In addition to employing MB and CDs as fluorescence donors, Yan et al fabricated a graphene quantum dot (GQD)-MnO 2 NS-based optical sensing platform for GSH detection ( Figure 5B ). properties are beneficial: a large specific surface area and a sensitive response to the tumor microenvironment. In 2013, Zhao et al proposed a novel and facile strategy for the fabrication of multifunctional nanocomposites with silica-coated Fe 2 O 3 particle cores and NaYF4‫׃‬Yb, Er shells, on which MnO 2 NSs were further grown for delivery and release of a model drug, Congo red (CR). In this nanosystem, the MnO 2 NSs served not only as carriers for the loading and release of CRin vitro but also as efficient quenchers for the UC luminescence to monitor intracellular GSH concentration (Figure 7 ). 138 The drug was released upon reduction of MnO 2 to Mn 2+ by GSH, while simultaneously increasing the UC luminescence. The fabricated nanocomposite is a promising platform due to its GSH-stimulated smart drug delivery and UC luminescence monitoring. Indeed, the nanocarrier functionality of MnO 2 NSs has rarely been applied individually and has always been combined with other pragmatic components, eg, fluorescence quenchers and magnetic resonance imaging (MRI) probes, which will be mentioned below.
As an MRI pro-contrast agent: stimuli-activated imaging based on MnO 2 NSs MRI was originally known as nuclear magnetic resonance (NMR) 139 imaging and belongs to a configuration of NMR, albeit the "nuclear" employed in the acronym was omitted to avoid negative associations with the word. Certain atomic nuclei are capable of absorbing and releasing radiofrequency (RF) energy in the presence of an external magnetic field. Hydrogen atoms are typically applied to boost the detectable RF signals which can be received by antennas in proximity to the corresponding anatomy for examination. By altering the parameters of the pulse sequence, different degrees of contrast may be generated between tissues based on the relaxation properties of their hydrogen atoms. 140, 141 Compared with other imaging modalities, the main advantage of MRI is its superb spatial resolution whereas its major drawback is the limited sensitivity. As such, chemistry and materials science research has focused on searching for solutions capable of solving this challenging hurdle 142 The introduction of contrast ), which was ascribed to the high valence (IV) of manganese and the shielded paramagnetic centers being inaccessible to water molecules. 151 Upon disintegration and degradation, the ) and 120-fold (from 0.42 to 50.57 mM
) enhancement, respectively, when the MnO 2 NSs were reduced to Mn 2+ by GSH ( Figure 8A ). 150 The decomposition of MnO 2 NSs in the tumor microenvironment (GSH-activated 152, 153 or pH-dependent 154, 155 ) to release Mn 2+ can be utilized for tumor cell MR imaging. Wang and Shi's group in 2014, presented an intriguing achievement with their report on an intelligent theranostic platform based on highly disperse 2D MnO 2 NSs for concurrent ultrasensitive pH-responsive MRI and drug delivery/release. 156 In addition to MRI, MnO 2 NSs have shown promising potential for the fabrication of dual-activatable fluorescence/ MRI bimodal platforms. In 2014, Tan and coworkers designed a redox-capable MnO 2 NS-aptamer nanoprobe for multimodal imaging of tumor cells ( Figure 8B) . 150 In this platform, the MnO 2 NSs played three roles as a DNA nanocarrier, fluorescence quencher and intracellular GSHactivated MRI CA. Upon encountering the target cells, the binding of the aptamer to the corresponding target weakened the absorption of the probe on the NSs and produced a fluorescence recovery as well as aptamer-mediated endocytosis. NSs into a large amount of Mn 2+ suitable for MRI. Using a similar principle, a MnO 2 NS-Ru(II) complex nanoarchitecture, Ru(BYP) 3 @MnO 2 (BYP = 2,2ʹ-bipyridine) has also been developed for determining GSH in vitro and in vivo. 157 Despite the multimodal imaging applications of MnO 2 NSs in conjunction with their fluorescence and MR imaging, many exploits have been attempted to accomplish theranostic applications (ie, imaging and killing at the same time). Notably, the PEG-MnO 2 NSs reported by Wang and colleagues in 2014 promoted ultrasensitive pHtriggered concurrent diagnostic and therapeutic functionalities (designated as theranostics) for cancers, which provided a novel and facile platform for concurrent ultrasensitive pH-stimulated T 1 -weighted MRI and anti-tumor drug (doxorubicin, Dox) release (Figure 9 ). 156 The pHtriggered rapid decomposition of 2D MnO 2 NSs in a mildly acidic microenvironment could facilitate the controlled release of delivered anticancer agents and circumvent the multidrug resistance of cancer cells by bypassing the typical P-glycoprotein (P-gP)-induced efflux process with MnO 2 NSs due to their larger size than free Dox molecules.
158
MnO 2 NSs themselves can be used not only as nanocarriers for drug delivery, but also as therapy agents. Recently, Xiaoyuan Chen and colleagues at the National Institute of Health (NIH) reported that the construction of MnO 2 -based nanoagents can augment the efficiency of CDT (Figure 10 ). 21 CDT utilizes iron-initiated Fenton chemistry to kill tumor cells via the conversion of endogenous H 2 O 2 into hydroxyl radicals (·OH), which have a high toxicity, inducing intracellular oxidative stress. [159] [160] [161] [162] To date, a number of ironcarrying nanoparticles have been employed as CDT agents to induce ferroptosis 163 in tumor cells via H 2 O 2 -dependent Fenton-like reaction. [164] [165] [166] [167] As envisaged, the overproduction of GSH in tumor cells ought to be one of the most formidable hurdles for the CDT effect in that GSH serves as a scavenger of the highly reactive ·OH generated by chemodynamic agents, thereby increasing the resistance of cancer cells to oxidative stress and diminishing the efficacy of CDT. 168, 169 Chen et al was the first time to report that MnO 2 , which possesses both Fenton-like Mn 2+ delivery and GSH depletion capabilities, could play a role as a novel chemodynamic agent in order to improve the CDT of cancer via simultaneously disrupting the antioxidant system and loading an ·OH generator into cells. Ultimately, they utilized MnO 2 NSs to successfully construct an activatable theranostic nanosystem for an MRI-monitored chemochemodynamic combination regimen. 21 In conclusion, as an MRI CA, MnO 2 NSs can produce an activatable MRI signal upon the degradation of their structure in the tumor microenvironment, favoring the improvement of the signal-to-noise ratio and specificity. Additionally, benefitting from the high surface area, fluorescence quenching ability and CDT ability of MnO 2 NSs, MRI-based theranostic platforms and multimodal imaging nanoprobes can be easily fabricated with the help of MnO 2 NSs, which undoubtedly broadens the applications of MRI.
Taken together, MnO 2 NSs have displayed promising potential in multiple modalities for the diagnosis, treatment and theranostics of tumors in vitro and in vivo. 
Conclusion and perspectives
Over the last few decades, research on the synthesis and biomedical applications of Last but not the least, biosafety is one of the most concerning issues for the use of nanomaterials in biomedical employments before end-point clinical translation, despite the knowledge of the toxicity for MnO 2 NSs are still very preliminary and limited. Therefore, the toxicity of MnO 2 NSs should be systematically and comprehensively validated, especially in vivo. In addition, several intermediate metabolites accumulate in living organisms and cannot be easily degraded or detoxified, resulting in long-term toxicity issues, which should be further considered.
In the future, for MnO 2 NS-related research, the biosafety should be considered first. Thus, green synthetic approaches are preferred for obtaining MnO 2 NSs with controllable thicknesses, sizes and morphologies. The biomedical applications of MnO 2 NSs have experienced markedly rapid advancement over the last few decades. However, the targets are relatively limited. Extra attention should be paid to integrating proper targeting aptamers/antigens/antibodies especially those that play important roles in cancer cell signaling pathways with MnO 2 NSs. This will help to improve both the performance of biosensors and the efficacy of cancer theranostics based on MnO 2 NSs. Furthermore, additional applications of MnO 2 NSs such as PTT and imaging-guided combination therapy, should be considered to broaden their biomedical applications. As envisaged optimistically, the MnO 2 NSs will provide promising opportunities for the realization of more advanced medical imaging. We also believe that this review may entice other scientists in multiple disciplines to join into this new but growing research field. Abbreviations: CCK-8, cell counting kit-8; NS, nanosheet; GQD, graphene quantum dot.
